Hide Board Information

Show Board Information

Stevia First Corp STVF

Board Mod: geneboyblake

Asst Mods:

Last Post: 07/16/2014 1:06:59 PM

Board Marks: 0

Posts Today: 0

Board Views Today: 4

Stevia First Corp (OTCMRKTS: STVF) Stock Message Board

1. STVF Company Profile

    

2. STVF Time & Sales

    

3. STVF Recent News

    

4. STVF Filings

    

5. STVF Financials

    

6. STVF Buy Rating

Create New Post View All Posts Board Mark Banned

Post

Subject

Author

Posted On

7	STVF Financials 07/16/2014 12:07:03 Stevia First	Emylers	07/16/2014 1:06:59 PM
6	$STVF . b	PoemStone	06/18/2014 11:48:53 AM
5	$STVF upturn ga	PoemStone	04/28/2014 11:22:12 AM
4	Latest Stevia First Corp (STVF) Headlines Stevia	Stock_Tracker	03/11/2014 2:01:56 PM
3	STVF 0.47 Stock Charts $STVF 1 Month Chart	chartguy89	03/10/2014 1:54:40 AM
2	STVF Stock Charts Last: +0.005 Saturday, March 1,	chartguy89	03/01/2014 8:26:34 PM
1		geneboyblake	03/05/2013 12:57:22 PM

Recent Articles

• PayPoint plc Announces General Meeting Results and Resolutions
• Royalty Pharma Announces Fourth Quarter Dividend for 2025
• Dogness Corporation Showcases Impressive Financial Growth
• Analysts Initiate Coverage on Notable Stocks with Insights
• Transform Your QuickBooks Experience with Innovative Solutions
• Mainscape’s Employee-Centric Vision for Sustainable Growth
• MDA Space to Announce Q3 2025 Results and Host Conference
• Join Joe Cecala for Insightful Webinar on Capital Markets
• Nano Positioning Systems Market Forecast to Reach $301.97 Billion
• Elevating Mental Health Services with Ira Hays at Innerspace
• Innovative AI Technology Transforming Derivatives Trading Today
• VEVOR Launches Hybrid Heat Press for Creative Freedom and Quality
• Transforming Global Payments: The Promise of Lightspark Grid
• Simplilearn Secures Spot in GSV 150 for 2026: A Transformative Journey
• Royalty Pharma Announces Upcoming Dividend Payments for Investors
• Metallus Prepares for Upcoming Third Quarter Earnings Call
• Evaxion's EVX-01 Demonstrates Unprecedented Cancer Vaccine Efficacy
• WillScot's Enhanced Credit Facility: A Step Towards Growth
• SRx Health Solutions' NYSE American Listing Update Explained
• Total Energy Services Inc. Sets Plan for Share Repurchase
• Banzai's Bold Move to Strengthen Finances Through Debt Strategy
• Westwood Holdings Group's Upcoming Conference Call on Q3 2025
• SEALSQ Launches Revolutionary Quantum-Resistant ASIC Technology
• MAX Power Partners with Leading Contractor to Drill Natural Hydrogen Well
• PodcastOne Launches Innovative K-Pop Podcast Series with BuzzFeed
• Lancaster Resources Celebrates Major Milestone at Gold Project
• Integral Metals Engages Investors with Flow-Through Placement
• Key Modifications Unveiled for the Sprott Uranium ETF Index
• New Clinical Insights on Solnerstotug for Resistant Tumors
• Karat Packaging Moves Headquarters for Streamlined Operations
• Vor Bio's Pioneering Research in IgA Nephropathy Presentation
• Kiniksa Pharmaceuticals Develops Promising Treatment for Pericarditis
• VolitionRx Supports Crisis Response Dogs with Cancer Tests
• Kisqali® Shows Promising 5-Year Results for Breast Cancer
• Visteon Corporation Announces Exciting Dividend for Shareholders
• Agios Pharmaceuticals Advances Treatment of Thalassemia with PYRUKYND
• BancFirst Corporation: Strong Third Quarter Earnings Report
• Vor Bio's Major Milestone Announced at Kidney Week Event
• Chery Super Hybrid Test Concludes Triumphantly, Ushering New Innovations
• Banzai International Reduces Debt: A Stronger Future Ahead
• Pirelli Cyber Tyre Triumphs at Autotech Awards for Innovation
• IMUNON Showcases Innovative Vaccine Technology at Key Conferences
• MAX Power Mining Champions Canada's First Hydrogen Well Venture
• Exploring Groundbreaking AD109 Data for Obstructive Sleep Apnea Treatment
• Advancements in Value-Based Care Through Zus Health's Innovations
• Hingham Schools Launch Innovative Electric Bus Initiative
• Investor Insights: Recent Investigations on Key Companies
• Rental Market Shows Signs of Affordability Improvement
• Paramount Skydance Corporation Announces Q3 2025 Results Preview
• Groundbreaking Results for Verzenio in Early Breast Cancer